ArticleHeliyon2022
Seroprevalence and associated risk factors of pox infection among sheep and goats in selected districts of Afar region, Ethiopia.
Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 6 citations in OpenAlex.
- Optimal immunization strategies for Saanen goats against goatpox.BMC veterinary research · 2025Article
- Worldwide Trend Observation and Analysis of Sheep Pox and Goat Pox Disease: A Descriptive 18-Year Study.Viruses · 2025Article
- Important Diseases of Small Ruminants in Sub-Saharan Africa: A Review with a Focus on Current Strategies for Treatment and Control in Smallholder Systems.Animals : an open access journal from MDPI · 2025Review
- Seroprevalence and risk factors for sheep pox and goat pox among small ruminant herds from Nakapiripirit and Sembabule districts, Uganda.Frontiers in veterinary science · 2025Article
- Seroprevalence and risk factors of sheep and goat pox virus in selected districts of Wolaita Zone, Southern Ethiopia.Journal of veterinary science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sheep and goat pox virus infection is highly devastating viral disease of small ruminants that cause severe production losses in sheep and goats in Ethiopia and also limits international trade. A cross-sectional study was employed with the objective to estimate the seroprevalence of pox infection and to assess associated risk factors during the study period, February to April, 2020. A total of 384 serum samples were collected from apparently healthy sheep and goats. Serum neutralization test was used to detect the presence of antibodies against pox virus at national veterinary institute. Descriptive statistics, univariable and Multivariable logistic analyses were used in this study. Results: The overall animal level seroprevalence of sheep and goat pox virus was found to be 15.36% (n = 59/384) and species level prevalence rate was found to be 14.5% (n = 16/110) in sheep and 15.69% (n = 43/274) in goats in the study areas. Among the associated factors considered in this study, sex (P = 0.010), age (P = 0.012) and herd size (P = 0.029) were found to be statistically associated with seropositivity of pox infection in multivariable logistic regression. The odds of seropositivity in female animals were 3.9 times more likely to develop pox infection than male animals (AOR = 2.2; 95% CI = 1.203-4.015%) and the odds of young animals were 2.14 times more likely to be seropositive to pox infection than old aged animals (AOR = 2.14; 95% CI = 1.169-3.633%). Moreover, the odds of large-sized flocks of animals were 3.10 times more likely to be seropositive to pox disease than small-sized flocks (AOR = 3.10; 95% CI = 1.30-4.42%). Conclusion: This study finding revealed that sheep and goat pox virus is prevalent and widespread diseases of small ruminant in afar region. Therefore, further study should be carried out to estimate region wise magnitude of the disease and control measures should be put in place to minimize the economic losses associated with this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.